Literature DB >> 23623137

Garlic (Allium sativum) attenuate glomerular glycation in streptozotocin-induced diabetic rats: A possible role of insulin.

Khaled K Al-Qattan1, Martha Thomson, Muslim Ali, Mohamed H Mansour.   

Abstract

OBJECTIVE: This study investigated the effect of fresh garlic aqueous extract on glomerular glycation in streptozotocin-induced diabetic rats.
METHOD: Serum insulin and glucose, in addition to renal corpuscles and erythrocyte hemoglobin glycation were determined in normal saline-treated normal rats (NS-NR), normal saline-treated diabetic rats (NS-DR) and garlic-treated diabetic rats (G-DR).
RESULTS: Compared to NS-NR, NS-DR showed significant decrease in serum insulin and increase in serum glucose and hemoglobin glycation. NS-DR also showed intense, diffused glomerular periodic acid Schiff activity. Compared to NS-DR, G-DR showed significant increase in serum insulin and decrease in serum glucose and hemoglobin glycation. Furthermore, the G-DR glomerular periodic acid Schiff activity and distribution was almost restored to that observed in NS-NR.
CONCLUSION: Garlic may attenuate glomerular glycation in streptozotocin-induced diabetic rats. This effect could be partially mediated via euglycemia induced by revitalization of endogenous insulin.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Year:  2013        PMID: 23623137     DOI: 10.1016/j.pathophys.2013.04.001

Source DB:  PubMed          Journal:  Pathophysiology        ISSN: 0928-4680


  2 in total

Review 1.  New Pathogenic Concepts and Therapeutic Approaches to Oxidative Stress in Chronic Kidney Disease.

Authors:  José Pedraza-Chaverri; Laura G Sánchez-Lozada; Horacio Osorio-Alonso; Edilia Tapia; Alexandra Scholze
Journal:  Oxid Med Cell Longev       Date:  2016-06-27       Impact factor: 6.543

2.  Garlic Attenuates Plasma and Kidney ACE-1 and AngII Modulations in Early Streptozotocin-Induced Diabetic Rats: Renal Clearance and Blood Pressure Implications.

Authors:  Khaled K Al-Qattan; Martha Thomson; Divya Jayasree; Muslim Ali
Journal:  Evid Based Complement Alternat Med       Date:  2016-05-18       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.